NCT05525481View on ClinicalTrials.gov

Tamoxifen Prediction Study in Patients With ER+ Breast Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

February 28, 2024

Conditions
ER+ Breast Cancer
Interventions
DRUG

Tamoxifen

Hormone therapy

Trial Locations (1)

3065NB

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER